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Introduction / objectives
Surveillance data needs to be capable of; identifying clus-
ters; tracking trends; assessing the effectiveness of inter-
ventions; and providing timely results. This research
assesses whether this is the case for healthcare-associated
infection (HCAI) and antimicrobial resistance (AMR)
surveillance systems in England, and endeavours to
understand why in certain areas surveillance has not
been more successful.
Methods
A systematic search of the literature was carried out.
Original search results identified additional Government,
committee and conference reports and guidelines.
Results
Surveillance of HCAIs and AMR has developed over
time in response to numerous stimuli. The implementa-
tion of novel surveillance systems are often in response
to issues identified through passive surveillance and
research. Evidence of rising infection or resistance rates
have caught the attention of the Government (and the
media) occasionally leading to enhanced surveillance of
specific infections to monitor progress towards targets.
Several independent studies have concluded that post-
discharge surveillance after surgery is required to pro-
vide more accurate surgical site infection rates. Funding
for surveillance programmes has come from various
sources including the pharmaceutical industry, particu-
larly in AMR surveillance.
Conclusion
Some surveillance schemes have been successfully imple-
mented, partially fulfilling criteria. However, many clini-
cal areas have yet to see advances in HCAI surveillance
specific to their area and are reliant upon generic passive
surveillance systems. Future development of surveillance
systems to rapidly identify clusters and outbreaks, and
patients at increased risk of acquiring infection will
ensure that control measures are best directed to prevent
further cases occurring.
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